These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20385755)

  • 1. Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax.
    Winterroth L; Rivera J; Nakouzi AS; Dadachova E; Casadevall A
    Infect Immun; 2010 Jun; 78(6):2890-8. PubMed ID: 20385755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.
    Reason D; Liberato J; Sun J; Keitel W; Zhou J
    Infect Immun; 2009 May; 77(5):2030-5. PubMed ID: 19223482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies.
    Brossier F; Lévy M; Landier A; Lafaye P; Mock M
    Infect Immun; 2004 Nov; 72(11):6313-7. PubMed ID: 15501759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
    Pohl MA; Rivera J; Nakouzi A; Chow SK; Casadevall A
    Infect Immun; 2013 Jun; 81(6):1880-8. PubMed ID: 23509144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates from B. anthracis spore challenge.
    Mett V; Chichester JA; Stewart ML; Musiychuk K; Bi H; Reifsnyder CJ; Hull AK; Albrecht MT; Goldman S; Baillie LW; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():183-90. PubMed ID: 21270531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
    Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse monoclonal antibodies to anthrax edema factor protect against infection.
    Leysath CE; Chen KH; Moayeri M; Crown D; Fattah R; Chen Z; Das SR; Purcell RH; Leppla SH
    Infect Immun; 2011 Nov; 79(11):4609-16. PubMed ID: 21911463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapies against anthrax.
    Chen Z; Moayeri M; Purcell R
    Toxins (Basel); 2011 Aug; 3(8):1004-19. PubMed ID: 22069754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.
    Taft SC; Weiss AA
    Clin Vaccine Immunol; 2008 Jan; 15(1):71-5. PubMed ID: 18032590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
    Reason D; Liberato J; Sun J; Camacho J; Zhou J
    Toxins (Basel); 2011 Aug; 3(8):979-90. PubMed ID: 22069752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
    Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
    J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.
    Ngundi MM; Meade BD; Little SF; Quinn CP; Corbett CR; Brady RA; Burns DL
    Clin Vaccine Immunol; 2012 May; 19(5):731-9. PubMed ID: 22441391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-fragment of edema factor as a candidate antigen for immunization against anthrax.
    Zeng M; Xu Q; Hesek ED; Pichichero ME
    Vaccine; 2006 Jan; 24(5):662-70. PubMed ID: 16157430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
    Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
    Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
    Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
    J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.